Genomics medicine strategy launched to improve outcomes for patients
Health Secretary Neil Gray hailed the plan.
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.A five-year strategy for developing a “world-class” gene-based medicine service in Scotland has been unveiled by the Scottish Government.
The strategy will look to increase the availability of genomic testing, where a patient’s genetic information is used to diagnose and treat disease more effectively, with a focus on improving outcomes for patients suffering from cancer and rare conditions.
While genomic testing is already widely used in the NHS, this is the first strategy to co-ordinate the approach to genomic medicine across Scotland.
Health Secretary Neil Gray said: “This new strategy marks the first step towards developing a world-class genomic medicine service in Scotland that is agile enough to grasp the opportunities presented by this exciting and fast-growing discipline.
“Embracing new technology is a major part of our plans to reform and recover Scotland’s NHS and a co-ordinated approach to this innovation will improve the care provided by our health service.
“Genomic technology is key to that because it will help with the transition to more efficient ways of delivering services, including deployment of staff, skills and equipment.
“Most importantly, it will support better diagnosis and access to the right treatment by ensuring access to the right tests at the right time.
“That will ultimately mean people having better outcomes.”